Literature DB >> 10887243

Islet cell tumor of the pancreas: biphasic CT versus MR imaging in tumor detection.

T Ichikawa1, M S Peterson, M P Federle, R L Baron, H Haradome, Y Kawamori, S Nawano, T Araki.   

Abstract

PURPOSE: To compare the effectiveness of biphasic computed tomography (CT) and magnetic resonance (MR) imaging in the detection of pancreatic islet cell tumors.
MATERIALS AND METHODS: Retrospective quantitative, qualitative, and receiver operating characteristic analyses of biphasic CT and MR imaging were performed in 19 patients with 26 histopathologically proved islet cell tumors. Delayed arterial dominant-phase (AP) and portal venous-phase (PVP) biphasic CT was performed after the administration of contrast material. MR imaging included T1-weighted spin-echo (SE) and T2-weighted SE or fast SE imaging, fat-saturated T1-weighted SE imaging, dynamic contrast material-enhanced T1-weighted gradient-echo imaging, and delayed enhanced T1-weighted SE imaging with or without fat saturation.
RESULTS: PVP CT and delayed enhanced T1-weighted MR imaging had the highest A(z) values (0.98 and 0.97, respectively; P <.05). Delayed enhanced T1-weighted MR imaging had the highest relative sensitivity (14-15 [74%-79%] of 19 lesions), followed by PVP CT (18-19 [69%-73%] of 26 lesions), AP CT (17-19 [65%-73%] of 26 lesions), fat-saturated T1-weighted MR imaging (eight to 10 [57%-71%] of 14 lesions), T2-weighted (16-17 [62%-65%] of 26 lesions), T1-weighted (15-18 [58%-69%] of 26 lesions) MR imaging, and dynamic MR imaging (nine [56%] of 16 lesions).
CONCLUSION: Biphasic (especially PVP) CT and MR imaging have similar effectiveness in the detection of islet cell tumors if fat-saturated T1-weighted and delayed enhanced T1-weighted MR imaging are included.

Entities:  

Mesh:

Year:  2000        PMID: 10887243     DOI: 10.1148/radiology.216.1.r00jl26163

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  51 in total

1.  Neuroendocrine tumors of the pancreas: benefits of new technologies.

Authors:  A Rosiere; S Mulier; L Michel; J E Donckier
Journal:  Surg Endosc       Date:  2005-04-28       Impact factor: 4.584

Review 2.  Recent advances in the imaging of adrenal and neuroendocrine tumours.

Authors:  Priya Narayanan; Rodney Reznek
Journal:  Clin Med (Lond)       Date:  2009-08       Impact factor: 2.659

Review 3.  Imaging of neuroendocrine tumors of the pancreas.

Authors:  J L Fidler; C D Johnson
Journal:  Int J Gastrointest Cancer       Date:  2001

4.  Imaging of gastroenteropancreatic neuroendocrine tumors.

Authors:  Eik Hock Tan; Cher Heng Tan
Journal:  World J Clin Oncol       Date:  2011-01-10

5.  Pancreatic neuroendocrine tumor with cystlike changes: evaluation with MDCT.

Authors:  Satomi Kawamoto; Pamela T Johnson; Chanjuan Shi; Aatur D Singhi; Ralph H Hruban; Christopher L Wolfgang; Barish H Edil; Elliot K Fishman
Journal:  AJR Am J Roentgenol       Date:  2013-03       Impact factor: 3.959

6.  Preoperative assessment of nonfunctioning pancreatic endocrine tumours: role of MDCT and MRI.

Authors:  Giovanni Foti; Letizia Boninsegna; Massimo Falconi; Roberto Pozzi Mucelli
Journal:  Radiol Med       Date:  2013-07-25       Impact factor: 3.469

Review 7.  Morphological and functional investigations of neuroendocrine tumors of the pancreas.

Authors:  Philippe L Pereira; Jakub Wiskirchen
Journal:  Eur Radiol       Date:  2003-05-06       Impact factor: 5.315

Review 8.  Intrapancreatic accessory spleen: findings on MR Imaging, CT, US and scintigraphy, and the pathologic analysis.

Authors:  Se Hyung Kim; Jeong Min Lee; Joon Koo Han; Jae Young Lee; Kyoung Won Kim; Kyunghee C Cho; Byung Ihn Choi
Journal:  Korean J Radiol       Date:  2008 Mar-Apr       Impact factor: 3.500

Review 9.  Laparoscopic resection of pancreatic neuroendocrine tumors.

Authors:  Abbas Al-Kurd; Katya Chapchay; Simona Grozinsky-Glasberg; Haggi Mazeh
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

10.  The value of multidetector-row CT in the preoperative detection of pancreatic insulinomas.

Authors:  Y Liu; Q Song; H T Jin; X Z Lin; K M Chen
Journal:  Radiol Med       Date:  2009-09-30       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.